Clinico-histopathological characteristics of clopidogrel-induced hepatic injury: Case report and review of literature

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 8, 2006, Pages 931-934

  Höllmüller, Isolde ^a   Stadlmann, Sylvia ^a   Graziadei, Ivo ^a   Vogel, Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cholestatic hepatitis; Clopidogrel; Liver biopsy

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ACUTE HEPATITIS; AGED; CASE REPORT; DISEASE SEVERITY; HEPATOCANALICULAR CHOLESTASIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER DISEASE; LIVER NECROSIS; LIVER TOXICITY; MALE; PRIORITY JOURNAL; RENAL ARTERY ANEURYSM; RESTENOSIS; REVIEW; STENT; TOXIC HEPATITIS;

AGED, 80 AND OVER; DRUG-INDUCED LIVER INJURY; HEPATITIS, TOXIC; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 33745857995     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200608000-00022     Document Type: Review

References (10)

1. Lau WC, Gurbel PA, Watkins PB, Neer CJ, Hopp AS, Carville DC, et al. Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation 2004; 109:166-171.
2. Richter T, Mürfter ThE, Heinkele G, Pleiss J, Tatzel S, Schwab M, et al. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine. J Pharmacol Exp Ther 2004; 308:189-197.
3. Willens HJ. Clopidogrel-induced mixed hepatocellular and cholestatic liver injury. Am J Ther 2000; 7:317-318.
4. Duran Quintana JA, Jimenez Saenz M, Montero AR, Gutierrez MH. Clopidogrel probably induced hepatic toxicity [letter to the editor]. Med Clin (Barc) 2002; 119:37.
5. Beltran Robles M, Marquez Saavedra E, Sanchez Munoz D, Romero Gomez M. Hepatotoxicity induced by clopidogrel. J Hepatol 2004; 40:560-562.
6. Ramos Ramos JC, Sanz Moreno J, Calvo Carrasco L, Garcia Diaz JD. Clopidogrel-induced hepatotoxicity. Med Clin (Barc) 2003; 120:156-157.
7. Wolf I, Mouallem M, Rath S, Farfel Z. Clopidogrel-induced systemic inflammatory response syndrome. Mayo Clin Proc 2003; 78:618-620.
8. Maria VAJ, Victorino RMM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26:664-669.
9. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk for ischemic events (CAPRIE). Lancet 1996; 348:1329-1339.
10. Tsui PT, Lai ST, Leung WS, Mok NS, Wu CW, Lau ST, et al. Prolonged jaundice following percutaneous coronary intervention and ticlopidine therapy. Hong Kong Med J 2002; 8:57-59.